
Sign up to save your podcasts
Or


Episode Breakdown:
00:00 – Intro
00:30 – Catherine Mohr on solving wicked problems in healthcare
01:36 – From engineer to surgeon to global strategist
04:42 – Early Intuitive years: misunderstood startup to category leader
07:29 – Ad 1: Blue Goat Cyber
10:28 – Why she created the Intuitive Foundation
13:59 – Asia and Africa will dominate healthcare by 2050
17:59 – How to identify problems worth solving
22:17 – Behind the creation of the Ion platform
28:22 – Ad 2: Showpad
29:38 – How much disruption is too much in clinical innovation?
36:37 – AI won’t replace surgeons—but it will coach them
38:55 – Why access to surgery is a bigger crisis than HIV, TB, and malaria
46:11 – Training at the point of care: solving rural access
49:00 – Stanford’s simulation center and outcomes impact
54:48 – Can technology replace parts of surgical judgment?
1:00:16 – The biggest myth in global health (and how to fix it)
1:01:35 – Outro & CTA
Showpad has been helping medtech marketers use data and content to empower sellers to grow pipeline. Learn more at Showpad.com/StateofMedtech
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on:
Follow Omar M. Khateeb on
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
By State of MedtechEpisode Breakdown:
00:00 – Intro
00:30 – Catherine Mohr on solving wicked problems in healthcare
01:36 – From engineer to surgeon to global strategist
04:42 – Early Intuitive years: misunderstood startup to category leader
07:29 – Ad 1: Blue Goat Cyber
10:28 – Why she created the Intuitive Foundation
13:59 – Asia and Africa will dominate healthcare by 2050
17:59 – How to identify problems worth solving
22:17 – Behind the creation of the Ion platform
28:22 – Ad 2: Showpad
29:38 – How much disruption is too much in clinical innovation?
36:37 – AI won’t replace surgeons—but it will coach them
38:55 – Why access to surgery is a bigger crisis than HIV, TB, and malaria
46:11 – Training at the point of care: solving rural access
49:00 – Stanford’s simulation center and outcomes impact
54:48 – Can technology replace parts of surgical judgment?
1:00:16 – The biggest myth in global health (and how to fix it)
1:01:35 – Outro & CTA
Showpad has been helping medtech marketers use data and content to empower sellers to grow pipeline. Learn more at Showpad.com/StateofMedtech
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Follow The State of MedTech on:
Follow Omar M. Khateeb on
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.